June 24, 2026
VIA EDGAR
Cybin Inc., doing business as Helus Pharma
100 King Street West, Suite 5600
Toronto, Ontario
M5X 1C9
Dear Sirs/Mesdames:
| Re: | Cybin Inc. doing business as Helus Pharma (the "Company") Prospectus Supplement dated June 24, 2026 to the Short Form Base Shelf Prospectus dated September 17, 2025, as amended on December 19, 2025 (the "Prospectus Supplement") |
We hereby consent to the reference to our firm name under the heading "Documents Filed as Part of the Registration Statement" in the Prospectus Supplement, which forms part of the registration statement on Form F-10 (File No. 333-292294), filed by the Company with the United States Securities and Exchange Commission, and to the reference to our advice under the headings "Experts" and "Enforcement of Civil Liabilities for U.S. Investors".
Yours very truly,
"/s/ AIRD & BERLIS LLP"
